Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue ; volume:15 ; number:1 ; day:30 ; month:1 ; year:2024 ; pages:1-14 ; date:12.2024
Nature Communications ; 15, Heft 1 (30.1.2024), 1-14, 12.2024
- Urheber
-
Shi, Guoli
Li, Tiansheng
Lai, Kin Kui
Johnson, Reed F.
Yewdell, Jonathan W.
Compton, Alex A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-45075-8
- URN
-
urn:nbn:de:101:1-2024041011422361800717
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shi, Guoli
- Li, Tiansheng
- Lai, Kin Kui
- Johnson, Reed F.
- Yewdell, Jonathan W.
- Compton, Alex A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants
Determinants of spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
Omicron spike protein: a clue for viral entry and immune evasion
Structural insights into the modulation of coronavirus spike tilting and infectivity by hinge glycans
Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity
Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages
The SARS-CoV-2 Omicron BA.1 spike G446S mutation potentiates antiviral T-cell recognition
The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutralizing potency than serum antibodies
Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants
Determinants of spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
Omicron spike protein: a clue for viral entry and immune evasion
Structural insights into the modulation of coronavirus spike tilting and infectivity by hinge glycans
Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity
Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages
The SARS-CoV-2 Omicron BA.1 spike G446S mutation potentiates antiviral T-cell recognition
The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutralizing potency than serum antibodies
Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants
Determinants of spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
Omicron spike protein: a clue for viral entry and immune evasion
Structural insights into the modulation of coronavirus spike tilting and infectivity by hinge glycans
Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity
Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages
The SARS-CoV-2 Omicron BA.1 spike G446S mutation potentiates antiviral T-cell recognition
The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants